Janet Hegarty
Overview
Explore the profile of Janet Hegarty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
368
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stringer D, Gardner L, Shaw O, Clarke B, Briggs D, Worthington J, et al.
EClinicalMedicine
. 2023 Jan;
56:101819.
PMID: 36684392
Background: 3% of kidney transplant recipients return to dialysis annually upon allograft failure. Development of antibodies (Ab) against human leukocyte antigens (HLA) is a validated prognostic biomarker of allograft failure....
2.
Eddington H, Chinnadurai R, Alderson H, Ibrahim S, Chrysochou C, Green D, et al.
BMC Nephrol
. 2021 Mar;
22(1):106.
PMID: 33757437
Background: Secondary hyperparathyroidism may lead to increased cardiovascular risk. The use of cinacalcet may improve bone and cardiovascular health with improved parathormone (PTH) and phosphate control. Methods: This is an...
3.
Chinnadurai R, Huckle A, Hegarty J, Kalra P, Sinha S
J Nephrol
. 2021 Feb;
34(5):1537-1545.
PMID: 33548054
Background And Aims: Calciphylaxis is a rare condition associated with very high mortality in patients with end-stage kidney disease. Data from country-based registries have been an invaluable resource for a...
4.
Da Silva Lodge M, Abeygunaratne T, Alderson H, Ali I, Brown N, Chrysochou C, et al.
BMC Nephrol
. 2020 Dec;
21(1):532.
PMID: 33287730
Background: Patients undergoing haemodialysis (HD) are at higher risk of developing worse outcomes if they contract COVID-19. In our renal service we reduced HD frequency from thrice to twice-weekly in...
5.
Stringer D, Gardner L, Peacock J, Rebollo-Mesa I, Hilton R, Shaw O, et al.
Trials
. 2019 Aug;
20(1):476.
PMID: 31383029
Background: Chronic rejection is the single biggest cause of premature kidney graft failure. HLA antibodies (Ab) are an established prognostic biomarker for premature graft failure so there is a need...
6.
Green D, Vassallo D, Handley K, Ives N, Wheatley K, Chrysochou C, et al.
BMC Nephrol
. 2019 Jun;
20(1):220.
PMID: 31200662
Background: The ASTRAL trial showed no difference in clinical outcomes between medical therapy and revascularization for atherosclerotic renal vascular disease (ARVD). Here we report a sub-study using echocardiography to assess...
7.
Sykes L, Sinha S, Hegarty J, Flanagan E, Doyle L, Hoolickin C, et al.
BMJ Open Qual
. 2018 Dec;
7(4):e000308.
PMID: 30555931
Acute kidney injury (AKI) is a common syndrome that is associated with significant mortality and cost. The Quality Improvement AKI Collaborative at Salford Royal Foundation Trust was established to review...
8.
Humphreys J, Harvey G, Hegarty J
Nephron Extra
. 2017 May;
7(1):18-32.
PMID: 28553315
Background: Chronic kidney disease (CKD) is a worldwide public health issue. From 2009 to 2014, the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care...
9.
Youssouf S, Nache A, Wijesekara C, Middleton R, Lewis D, Shurrab A, et al.
Nephron
. 2017 Feb;
136(2):75-84.
PMID: 28237984
Background: Best practice in dialysis is synthesised in clear international guidelines. However, a large gap remains between the international guidelines and the actual delivery of care. In this paper, we...
10.
Ritchie J, Green D, Chrysochou T, Hegarty J, Handley K, Ives N, et al.
Nephrol Dial Transplant
. 2016 Jun;
32(6):1006-1013.
PMID: 27257278
Background: Cardiac abnormalities are frequent in patients with atherosclerotic renovascular disease (ARVD). The Angioplasty and Stenting for Renal Artery Lesions (ASTRAL) trial studied the effect of percutaneous renal revascularization combined...